Baupost Group 13F holdings, Q4 2014
Holdings as of December 31, 2014 · filings on SEC EDGAR · latest filing →
Baupost Group disclosed 27 US equity positions worth $5.1bn in its Q4 2014 13F filing. The largest position was LNG at 19.1% of the reported book, followed by VSAT and MU. Against the Q3 2014 filing, it opened 4 new positions, added to 8 and reduced 5 among the top 27 holdings.
What did Baupost Group own in Q4 2014? Top 27 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2014 |
|---|---|---|---|---|---|---|---|
| 1 | LNG CHENIERE ENERGY INC | Energy | 19.1% | $972.0m | 13,807,230 | 23% | added |
| 2 | VSAT VIASAT INC | Technology | 14.3% | $726.9m | 11,533,137 | 0% | held |
| 3 | MU MICRON TECHNOLOGY INC | Technology | 13.6% | $689.9m | 19,706,035 | -62% | reduced |
| 4 | EBAY EBAY INC | Consumer Cyclical | 10.3% | $522.8m | 9,315,000 | 53% | added |
| 5 | AR ANTERO RES CORP | Energy | 6.3% | $318.5m | 7,847,831 | 184% | added |
| 6 | THERAVANCE INC | 5.5% | $280.4m | 19,815,983 | 0% | held | |
| 7 | KERYX BIOPHARMACEUTICALS INC | 5.1% | $258.9m | 18,300,000 | 0% | held | |
| 8 | PBF PBF ENERGY INC | Energy | 4.5% | $230.8m | 8,663,114 | 21% | added |
| 9 | VERITIV CORP | 2.4% | $120.0m | 2,314,193 | -2% | reduced | |
| 10 | FORWARD PHARMA A/S | 2.2% | $111.8m | 5,367,300 | – | new | |
| 11 | TBPH THERAVANCE BIOPHARMA INC | Healthcare | 1.8% | $90.4m | 6,061,228 | 0% | held |
| 12 | OCWEN FINL CORP | 1.8% | $90.1m | 5,967,050 | -15% | reduced | |
| 13 | CITIGROUP INC | 1.8% | $89.3m | 102,673,007 | -16% | reduced | |
| 14 | SUNEDISON SEMICONDUCTOR LTD | 1.5% | $77.0m | 4,145,379 | 0% | held | |
| 15 | CHIPMOS TECH BERMUDA LTD | 1.5% | $76.6m | 3,283,235 | 0% | held | |
| 16 | BELLATRIX EXPLORATION LTD | 1.3% | $65.9m | 18,103,713 | – | new | |
| 17 | NG NOVAGOLD RES INC | Basic Materials | 1.3% | $64.0m | 21,688,300 | 0% | held |
| 18 | PARATEK PHARMACEUTICALS INC | 1.2% | $62.1m | 1,735,218 | – | new | |
| 19 | KOS KOSMOS ENERGY LTD | Energy | 1.2% | $60.8m | 7,242,354 | 52% | added |
| 20 | ATRA ATARA BIOTHERAPEUTICS INC | Healthcare | 1.2% | $59.1m | 2,495,913 | – | new |
| 21 | THERAVANCE INC | 0.6% | $31.4m | 40,089,000 | 135% | added | |
| 22 | SYNERON MEDICAL LTD | 0.4% | $22.5m | 2,416,310 | -19% | reduced | |
| 23 | KINDRED BIOSCIENCES INC | 0.4% | $22.5m | 3,013,848 | 0% | held | |
| 24 | AMERICAN INTL GROUP INC | 0.4% | $21.9m | 889,387 | 13% | added | |
| 25 | ALON USA PARTNERS LP | 0.2% | $12.3m | 954,188 | 190% | added | |
| 26 | ALLIANCE ONE INTL INC | 0.2% | $10.1m | 6,383,641 | 0% | held | |
| 27 | NOVACOPPER INC | 0.1% | $2.9m | 6,005,298 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.